Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2006
03/14/2006US7012069 For therapy of heart disease and stroke, Alzheimer's disease, and an inflammatory disorder
03/14/2006US7012062 Use of modified lysozyme C to prepare medicinal compositions for the treatment of some serious diseases
03/14/2006US7011828 Regeneration cells of nervous system
03/14/2006US7011820 Delivery of compounds for the treatment of Parkinsons through an inhalation route
03/14/2006CA2380810C Pyridomorphinans and use thereof
03/14/2006CA2359363C 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
03/14/2006CA2165800C Antiallergic imidazoazepines
03/14/2006CA2051494C 1-aryl-3-pyridinyl-2-propene-1-ones as calcium uptake inhibitors
03/09/2006WO2006025580A1 Anti-histone h1 monoclonal antibody and hybridoma capable of producing the same
03/09/2006WO2006025345A1 Antihuman baff antibody
03/09/2006WO2006025286A1 Constitutional function-improving agents
03/09/2006WO2006024958A2 Cannabinoid compositions and methods of use thereof
03/09/2006WO2006024367A2 Use of nkg2d receptor/nkg2d ligand interaction blockers in the treatment of auto-immune diseases
03/09/2006WO2006004924A3 Imidazolo-related compounds, compositions and methods for their use
03/09/2006WO2005097751A3 Non-imidazole heterocyclic compounds as histamine h3-receptor ligands
03/09/2006WO2005087238A3 Method for stimulating the immune, inflammatory or neuroprotective response
03/09/2006WO2005014572A8 Pyrimidylpyrrole derivatives active as kinase inhibitors
03/09/2006US20060052610 Piperidine derivatives and process for their production
03/09/2006US20060052594 New corticosteroids
03/09/2006US20060052593 diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions
03/09/2006US20060052591 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
03/09/2006US20060052585 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
03/09/2006US20060052419 Use of pyridly amides as inhibitors of angiogenesis
03/09/2006US20060052411 Immunosuppressants, analgesics, antiinflammatory agents
03/09/2006US20060052407 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist
03/09/2006US20060052406 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
03/09/2006US20060052403 Novel adenine compound and use thereof
03/09/2006US20060052400 Immunosuppressants; respiratory system disorders; asthma; chronic obstructive pulmonary disease
03/09/2006US20060052379 Pyridazin-3(2h)-one derivatives as pde4 inhibitors
03/09/2006US20060052371 2-(3-cyanophenyl)-4H-1,3-benzothiazin-4-one; cardiovascular, bone or joint diseases, infectious, inflammatory, kidney diseases; safe and good effects of cell death inhibition, Migration Inhibitory Factor (MIF) binding
03/09/2006US20060052329 Regulation of human P2Y1-like G protein-coupled receptor
03/09/2006US20060051836 Molecules for disease detection and treatment
03/09/2006US20060051379 Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria minigitidis
03/09/2006US20060051367 Antigenic polypeptide sequences of factor VIII, and fragments and/or epitopes of these sequences
03/09/2006US20060051357 Tolerance induction with help of a combination of a lfa-1 inhibitor and a costimulation inhibitor and or a mtor inhibitor
03/09/2006US20060051350 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (GITR or TNFRSF18)
03/09/2006US20060051349 Immunotherapy of autoimmune disorders using antibodies which target B-cells
03/09/2006CA2752569A1 .delta.-amino acid as an exercise function-improving agent
03/09/2006CA2578995A1 2,4,6-triamino-s-triazine-based compounds which bind to the tail (fc) portion of immunoglobulins and their use
03/09/2006CA2577702A1 New polymorphic form of inulin and uses thereof
03/09/2006CA2577311A1 Pharmaceutical multiparticulate compositions comprising mycophenolic acid or mycophenolate sodium and combination compositions with rapamycin
03/08/2006EP1632489A1 5-(1,1'-Biphenyl)-4-yl-5-(4-(4-aminoacylphenyl)-piperazin)-1-yl-pyrimidine-2,4,6-trione derivatives, as inhibitors of zinc metallondopeptidases, their preparation and use.
03/08/2006EP1632488A1 Cyclic tertiary amine compound
03/08/2006EP1632479A2 Piperazine derivatives useful as ccr5 antagonists
03/08/2006EP1631586A2 Peptide analogues comprising at least one type of aminoacyl aza-beta 3 and the use thereof, in particular for therapy
03/08/2006EP1631287A2 Novel long-acting medicament combinations comprising an anticholinergic agent and a $g(b)2-adrenoreceptor antagonist for the treatment of respiratory tract diseases
03/08/2006EP1494703B1 Chemokines mutants having improved oral bioavailability
03/08/2006EP1451167B1 Phenylalkynes
03/08/2006EP1448592B1 Steroidal compounds for inhibiting steroid sulphatase
03/08/2006EP1438341B1 Antibody stimulating il-1ra production
03/08/2006EP1404667B1 Piperidine derivatives useful as modulators of chemokine receptor activity
03/08/2006EP1347966B1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
03/08/2006EP1343784B1 UREA SUBSTITUTED IMIDAZOQUINOLINE ETHERS and pharmaceutical compositions comprising the same.
03/08/2006EP1326589B1 Nanoparticles
03/08/2006EP1325009B1 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
03/08/2006EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands
03/08/2006EP1274407B1 Uses of ppar-gamma agonists in neutrophil-induced diseases
03/08/2006EP1272213B1 Microbial delivery system
03/08/2006EP1267886B1 Vitamin d compounds for the treatment of chronic allograft nephropathy in kidney transplant patients
03/08/2006EP1240179B1 3-methylene steroid derivatives for the treatment of autoimmune diseases
03/08/2006EP1230338B1 Continuous-flow method for preparing microparticles
03/08/2006EP1220611B1 Suppressor cells for prevention and treatment of immune responses in transplantation
03/08/2006EP1150704B1 Melagatran for the treatment of inflammation
03/08/2006EP1123396B1 Minimal promoters and uses thereof
03/08/2006EP1032662B1 Methods and compositions for immunomodulation
03/08/2006EP0977568B1 Benzocycloheptathiophene compounds
03/08/2006EP0946730B1 Mutants of streptococcal toxin c and methods of use
03/08/2006EP0841945B1 Cell derived antigen presenting vesicles
03/08/2006EP0553291B1 Treatment of autoimmune diseases by oral administration of autoantigens
03/08/2006CN1745099A 修饰的可溶性t细胞受体 Modified soluble t-cell receptor
03/08/2006CN1745080A 1,3-dihydroimidazole fused-ring compound
03/08/2006CN1744910A Drugs containing galectin 9
03/08/2006CN1743329A Hexahydro-pyrazino-pyridino-indole dione, and its synthesis and use
03/08/2006CN1743328A Hexahydro-pyrazino-pyridino-indole, and its systhesis and use
03/08/2006CN1742997A Mimetics of interleukin-8 and use of them in the prevention, treatment, diagnosis of a disease
03/08/2006CN1742953A Plant cell regulator
03/08/2006CN1742951A Health-care preparation for reducing blood-fat and raising human-body immunity
03/08/2006CN1742929A Chinese herbal medicinal immune intensifier mode from left-eyed flounder and right-eyed flounder
03/08/2006CN1742761A Chinese medicine effective-part extract for treating hypersensitive diseases and extraction process
03/08/2006CN1244580C Aminothiazoles and their use as adenosine receptor antagonists
03/08/2006CN1244576C Chemical compounds
03/08/2006CN1244561C Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
03/08/2006CN1244334C Novel use of traditional Chinese medicine jujube
03/07/2006US7009049 Syntheses of quinazolinones
03/07/2006US7008962 Interleukin-8 (IL-8); compounds such as 3-(2-hydroxy-phenylamino)-4-(2-bromophenylamino)-cyclobut-3-ene-1,2-dione for treating chemokine-mediated diseases such as autoimmune diseases, septic shock, graft versus host disease, allograft rejections
03/07/2006US7008954 method of use to treat chronic graft versus host disease, autoimmune diseases, and other specified diseases by administering a tricyclic compound of given structure which includes a pyridyl ring, two phenyl rings and either an amino or oxy group
03/07/2006US7008946 CCR5 antagonists useful for treating AIDS
03/07/2006US7008943 1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
03/07/2006US7008938 Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient
03/07/2006US7008925 use for treatment of medical and veterinary conditions which can be influenced by the MC1-receptor; act as immunomodulators and to affect motivation, learning, memory, behaviour, inflammation, body temperature, pain, perception
03/07/2006US7008922 Transplantation antigen that can lead to rejection of HLA-matched male organ and bone marrow grafts by female recipients, and may play a role in pregnancy and spermatogenesis. However, the origin and function of H-Y
03/07/2006US7008630 Controlling cell differentiation, cell proliferation; antiinflammatory agents; skin disorders
03/07/2006US7008616 Ephedrine or fenfluramine; aluminum foil coated with a thin layer of drug is heated to form vapor; which condenses to form aerosol; rapid peak plasma concentration
03/07/2006US7008615 Delivery of anti-migraine compounds through an inhalation route
03/07/2006CA2220048C Acellular pertussis vaccines and methods of preparation thereof
03/02/2006WO2006023791A2 Methods and compositions for treating allergic inflammation
03/02/2006WO2006023639A1 Methods and compositions for oral delivery of fts
03/02/2006WO2006022450A1 Remedy for skin disease
03/02/2006WO2006022442A1 Novel heterocyclic amide derivatives having dihydroorotate dehydrogenase inhibiting activity
03/02/2006WO2006022409A1 Hazardous substance scavenger and application apparatus and application method therefor